1. Home
  2. ZBH vs CG Comparison

ZBH vs CG Comparison

Compare ZBH & CG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBH
  • CG
  • Stock Information
  • Founded
  • ZBH 1927
  • CG 1987
  • Country
  • ZBH United States
  • CG United States
  • Employees
  • ZBH N/A
  • CG N/A
  • Industry
  • ZBH Industrial Specialties
  • CG Investment Managers
  • Sector
  • ZBH Health Care
  • CG Finance
  • Exchange
  • ZBH Nasdaq
  • CG Nasdaq
  • Market Cap
  • ZBH 19.1B
  • CG 22.9B
  • IPO Year
  • ZBH N/A
  • CG 2012
  • Fundamental
  • Price
  • ZBH $100.92
  • CG $66.74
  • Analyst Decision
  • ZBH Buy
  • CG Hold
  • Analyst Count
  • ZBH 18
  • CG 15
  • Target Price
  • ZBH $112.00
  • CG $57.31
  • AVG Volume (30 Days)
  • ZBH 1.2M
  • CG 2.5M
  • Earning Date
  • ZBH 10-29-2025
  • CG 11-06-2025
  • Dividend Yield
  • ZBH 0.93%
  • CG 2.10%
  • EPS Growth
  • ZBH N/A
  • CG N/A
  • EPS
  • ZBH 4.11
  • CG 3.42
  • Revenue
  • ZBH $7,833,800,000.00
  • CG $5,525,600,000.00
  • Revenue This Year
  • ZBH $8.20
  • CG N/A
  • Revenue Next Year
  • ZBH $5.93
  • CG $19.87
  • P/E Ratio
  • ZBH $25.08
  • CG $19.46
  • Revenue Growth
  • ZBH 4.11
  • CG 99.03
  • 52 Week Low
  • ZBH $89.22
  • CG $33.02
  • 52 Week High
  • ZBH $114.72
  • CG $68.20
  • Technical
  • Relative Strength Index (RSI)
  • ZBH 44.87
  • CG 62.25
  • Support Level
  • ZBH $101.95
  • CG $62.71
  • Resistance Level
  • ZBH $104.49
  • CG $68.20
  • Average True Range (ATR)
  • ZBH 1.71
  • CG 1.63
  • MACD
  • ZBH -0.82
  • CG 0.08
  • Stochastic Oscillator
  • ZBH 0.55
  • CG 77.02

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

About CG The Carlyle Group Inc.

Carlyle Group is one of the world's largest alternative-asset managers, with $453 billion in total AUM, including $314 billion in fee-earning AUM, at the end of March 2025. The company has three core business segments: global private equity, which includes its private equity, real estate, infrastructure, and natural resources offerings (with $164 billion in total AUM and $99 billion in fee-earning AUM), global credit ($199 billion/$161 billion), and investment/fund solutions, known as Carlyle AlphInvest ($89 billion/$54 billion). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 3,100 active carry fund investors from 87 countries.

Share on Social Networks: